Position in SRPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$316,042
-$329,558 QoQ
Shares Held
14,524
-51.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 68.85155604516662.ToString("F0")%
Shared 31.148443954833375.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Mar 31, 2026CallValue
$3,377,152
CallShares
155,200
PutValue
$30,960,128
PutShares
1,422,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LMR Partners LLP holds $224,816,570 across 60 Biotechnology names. SRPT ranks #38 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
74,661 | $24,703,084 | |
| 2 | ACLX |
Arcellx, Inc.
|
212,495 | $24,398,675 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
400,000 | $21,088,000 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
324,939 | $18,355,804 | |
| 5 | ARGX |
Argenx SE
|
23,488 | $17,152,112 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
403,622 | $16,237,713 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,049,700 | $15,178,662 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
130,000 | $12,642,500 |
All Filings in SRPT
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,960,128 | 1,422,800 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $316,042 | 14,524 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $3,377,152 | 155,200 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $31,264,256 | 1,452,800 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $7,686,944 | 357,200 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $645,600 | 30,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $518,690 | 26,917 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $3,341,418 | 173,400 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $26,636,921 | 1,382,300 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $1,296,180 | 75,800 | Call | Sole | 2025-08-14 | |
| 2024-12-31 | $452,801 | 3,724 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,620,930 | 37,000 | Call | Sole | 2024-11-07 | |
| 2024-09-30 | $5,698,356 | 45,627 | Shares | Sole | 2024-11-07 | |
| 2024-09-30 | $10,952,853 | 87,700 | Put | Sole | 2024-11-07 | |
| 2024-06-30 | $10,917,800 | 69,100 | Call | Other | 2024-08-14 | |
| 2024-06-30 | $23,083,800 | 146,100 | Put | Other | 2024-08-14 | |
| 2024-06-30 | $9,613,352 | 60,844 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $17,399,424 | 134,400 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $13,321,434 | 102,900 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $22,661,050 | 235,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $2,184,525 | 22,654 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $18,697,777 | 193,900 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $44,511,984 | 367,200 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $22,437,822 | 185,100 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $38,822,280 | 339,000 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $25,182,948 | 219,900 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $6,130,540 | 44,479 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,473,682 | 19,090 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,602,001 | 23,539 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,519,953 | 113,660 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,824,613 | 61,759 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $466,206 | 5,997 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $8,863,093 | 51,986 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||